Stock listing

NASDAQ:XNPT XenoPort Inc Stock

Follow XenoPort Inc into a list and get an email when it puts out news.

Last close · NASDAQ:XNPT

$7.07 USD

Close on Jul 5, 2016 · No longer trades

Jun 2, 2005 to last close -32.0% · monthly closes, Jun 2, 2005 – Jul 5, 2016
Lowest – highest close
$3.28 – $65.86 USDSince Jun 2, 2005 · lowest May 9, 2014 · highest Jan 18, 2008

Delisted NASDAQ:XNPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:XNPT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

XenoPort Inc on 6ix

Decks
7 decks · latest Sep 15, 2015

Decks

DeckKindSlidesDate
Technical Presentation (September 2015)Technical21 slidesSep 15, 2015
Investor Presentation (October 2014)Investor deck45 slidesOct 16, 2014
Proxy Contest (June 2014)Proxy contest50 slidesJun 6, 2014
Proxy Contest (May 2014)Proxy contest51 slidesMay 29, 2014
Proxy Contest (May 2014)Proxy contest49 slidesMay 21, 2014
Proxy Contest (May 2014)Proxy contest52 slidesMay 21, 2014
Proxy Contest (May 2014)Proxy contest25 slidesMay 13, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jeryl Jeri Hilleman
Other companies: Omada Health, Inc. (Chair, Omada Health Board of Directors · Since at least Jun 5, 2025); Hillevax Inc (Director · Since at least Apr 28, 2022); SI-BONE, Inc. (Director · Since at least Dec 3, 2019); NovoCure Limited (Director · Since at least Jul 25, 2018); Cutera Inc (Director · Jul 12, 2024 – Oct 24, 2024 · Past); Talis Biomedical Corp (Director · Mar 16, 2021 – Mar 16, 2021 · Past); Minerva Neurosciences, Inc (Director · Jul 16, 2018 – Sep 27, 2023 · Past); Intersect ENT Inc (Chief Financial Officer · Jul 23, 2014 – May 7, 2019 · Past); Ocera Therapeutics Inc (CFO and Secretary · Sep 3, 2013 – Dec 19, 2013 · Past); Amyris Inc (Chief Financial Officer · Sep 27, 2010 – May 20, 2011 · Past); Symyx Technologies Inc (Exec. Vice President and CFO · Feb 15, 2006 – Mar 1, 2007 · Past)
Director · May 2, 2006 – Jul 5, 2016 · Past
John G. Freund
Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past)
Director · May 2, 2006 – Jul 5, 2016 · Past
Wendall Wierenga
Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past)
Director · May 7, 2009 – Jul 5, 2016 · Past
Dennis M Fenton
Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); AnaptysBio, Inc. (Director · Since at least Mar 5, 2018); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Pfenex Inc (Director · May 6, 2016 – May 5, 2017 · Past)
Director · May 17, 2016 – Jul 5, 2016 · Past
William Rieflin
Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past)
Director · May 17, 2016 – Jul 5, 2016 · Past
Gary D Tollefson
Other companies: Orexigen Therapeutics Inc (President and CEO, Director · Apr 25, 2007 – Aug 15, 2008 · Past); Cypress Bioscience Inc (Director · Jan 2, 2006 – Jan 2, 2007 · Past)
Director · Feb 15, 2006 – May 8, 2008 · Past
Kenneth Cundy
Other companies: Anebulo Pharmaceuticals, Inc. (Chief Scientific Officer · Since at least May 20, 2022); CohBar Inc (Chief Scientific Officer · Jul 18, 2018 – Aug 11, 2021 · Past)
SVP, Preclinical Development · Jan 31, 2006 – Mar 12, 2012 · Past
Ronald W Barrett
Other companies: Janux Therapeutics, Inc. (Director · Since at least Sep 7, 2021); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Jun 10, 2021 · Past)
Chief Executive Officer, Director · Jan 31, 2006 – Sep 1, 2015 · Past
William G Harris
Other companies: Soleno Therapeutics, Inc. (Director · Since at least Jul 6, 2017)
See Remarks · Feb 24, 2006 – Jul 5, 2016 · Past
David R SavelloSVP, Development · Feb 16, 2007 – Feb 24, 2014 · Past
All 17 people
PersonSeat
Gianna M BoskoSVP, CLO and Secretary · Aug 25, 2010 – Jan 13, 2015 · Past
Gregory T BatesSee Remarks · Jun 1, 2012 – Jul 5, 2016 · Past
Kim RichardSee Remarks · Jan 15, 2014 – Jul 5, 2016 · Past
Mark A GallopSVP, Research · Jan 3, 2006 – Feb 24, 2010 · Past
Pierre V TranSVP and Chief Medical Officer · Jan 31, 2006 – Jan 30, 2007 · Past
Robert OverellDirector · Jan 5, 2006 – Jan 5, 2006 · Past
Vincent AngottiCHIEF EXECUTIVE OFFICER, Director · May 1, 2008 – Jul 5, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about XenoPort Inc.